Bethesda, MD - Enhanced external counterpulsation therapy, typically known by its proprietary moniker EECP (Vasomedical), may have found a niche treating angina but remains controversial as a tool ...
WESTBURY, N.Y.--(BUSINESS WIRE)--March 10, 2006--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, reconfirmed that the majority of ...
Dr Gopalakrishnan A. Pillai, renowned heart surgeon and Medical Director of Aluva Heart Care Heart Institute, passed away on ...
“With these final roll-in results, this novel investigational therapy shows promise in addressing debilitating refractory angina, a significant unmet need for patients with chronic myocardial ischemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback